Dan Hartley
General Counsel en GENUS PLC .
Fortuna: 963 604 $ al 31/03/2024
Perfil
Dan Hartley is currently working as the Secretary & Group General Counsel at Genus Plc since 2014.
Prior to this, he worked as the Senior Vice President & International Counsel at Shire Plc.
Mr. Hartley completed his undergraduate degree from The University of Sydney and his graduate degree from the University of Wollongong.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENUS PLC
0.07% | 14/09/2023 | 43 218 ( 0.07% ) | 963 604 $ | 31/03/2024 |
Cargos activos de Dan Hartley
| Empresas | Cargo | Inicio |
|---|---|---|
| GENUS PLC | General Counsel | 09/06/2014 |
Antiguos cargos conocidos de Dan Hartley.
| Empresas | Cargo | Fin |
|---|---|---|
| SHIRE | General Counsel | - |
Formación de Dan Hartley.
| The University of Sydney | Undergraduate Degree |
| University of Wollongong | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GENUS PLC | Process Industries |
| Empresas privadas | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Dan Hartley
